The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?
Author:
Publisher
Informa UK Limited
Subject
Oncology
Reference97 articles.
1. NICE Decision Support Unit. NICE DSU technical support document 16: adjusting survival time estimates in the presence of treatment switching; 2014. Available from: http://nicedsu.org.uk/wp-content/uploads/2016/03/TSD16_Treatment_Switching.pdf. Accessed March 13, 2020.
2. Do cancer drugs improve survival or quality of life?
3. Perspectives to mitigate payer uncertainty in health technology assessment of novel oncology drugs
4. Association Between the Use of Surrogate Measures in Pivotal Trials and Health Technology Assessment Decisions: A Retrospective Analysis of NICE and CADTH Reviews of Cancer Drugs
5. Analysis of endpoints used in marketing authorisations versus value assessments of oncology medicines in Germany
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis;Expert Review of Anticancer Therapy;2023-10-25
2. Association Between Intermediate End Points, Progression-free Survival, and Overall Survival in First-line Advanced or Recurrent Endometrial Cancer;Clinical Therapeutics;2023-10
3. Time to deterioration of patient-reported outcomes as a surrogate of overall survival: a meta-analysis;JNCI: Journal of the National Cancer Institute;2023-08-04
4. Cancer Drugs Reimbursed with Limited Evidence on Overall Survival and Quality of Life: Do Follow-Up Studies Confirm Patient Benefits?;Clinical Drug Investigation;2023-07-28
5. An Investigation into the Relationship Between Choice of Model Structure and How to Adjust for Subsequent Therapies Using a Case Study in Oncology;Applied Health Economics and Health Policy;2023-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3